Bionic cloth for stopping bleeding

A technology of bionic cloth and breathable layer, which is applied in the field of medical supplies, can solve the problems of infectious diseases, poor tissue adhesion, and limited hemostatic effect, and achieve the effects of accelerating the activation of coagulation factors, strengthening magnetism and persistence, and promoting self-coagulation

Inactive Publication Date: 2018-08-10
朱梅佳
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

They have exact hemostatic effect, but they also have disadvantages: such as fibrin glue source, zeolite, fiber and other products, the cost is high, the fusion and absorption performance is poor, the scar repair is lacking, the performance is single, the hemostatic efficiency is low, the applicability is poor, and it is easy to infect diseases ;Collagen relies solely on the activation of platelets to stop bleeding, the hemostatic effect is limited, and the tissue adhesion is poor; Porous zeolite will release a lot of heat energy after absorbing blood water, which will lead to wound inflammation; Carboxymethyl cellulose soluble gauze cannot be degraded on the wound surface, Easy to produce scars when removed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bionic cloth for stopping bleeding
  • Bionic cloth for stopping bleeding

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] This embodiment provides a bionic cloth for hemostasis, including the bionic cloth for hemostasis having a multi-layer structure, in turn are a repair dissolving layer, an isolation breathable layer, a hemostatic medicinal material layer, and a package outer layer. The repair dissolving layer is cyanoacrylic. Tissue glue, the isolation and breathable layer is woven from cotton and linen fibers, the hemostatic medicinal material layer is a healing agent, and the outer layer of the wrapping is cotton and linen fiber cloth. At the same time, the preferred embodiment is as follows: the bionic cloth for hemostasis has a multilayer structure such as figure 1 As shown, the repair dissolving layer 10, the isolation breathable layer 20, the hemostatic medicinal material layer 30, and the wrapping outer layer 40 are in order. The repair dissolving layer 10 is cyanoacrylic tissue glue, and the isolation breathable layer 20 is woven from cotton and linen fibers. The hemostatic medic...

Embodiment 2

[0059] This embodiment provides a bionic cloth for hemostasis, which has a multilayer structure, such as figure 1 As shown, the repair dissolving layer 10, the isolation breathable layer 20, the hemostatic medicinal material layer 30, and the wrapping outer layer 40 are in order. The repair dissolving layer 10 is cyanoacrylic tissue glue, and the isolation breathable layer 20 is woven from cotton and linen fibers. The hemostatic medicinal material layer 30 is a medical agent, the protective fiber layer 40 is cotton and linen fiber cloth, and the repair dissolving layer 10, the isolation breathable layer 20, the hemostatic medicinal material layer 30 and the wrapping outer layer 40 are solidified together by cross-linking and pasting.

[0060] As a further improvement to the present invention, the thickness ratio among the repairing and dissolving layer 10, the insulating gas-permeable layer 20, the hemostatic medicinal material layer 30 and the wrapping outer layer 40 is 4:1:3:2. ...

Embodiment 3

[0079] This embodiment provides a bionic cloth for hemostasis, which has a multilayer structure, such as figure 1 As shown, the repair dissolving layer 10, the isolation breathable layer 20, the hemostatic medicinal material layer 30, and the wrapping outer layer 40 are in order. The repair dissolving layer 10 is cyanoacrylic tissue glue, and the isolation breathable layer 20 is woven from cotton and linen fibers. The hemostatic medicinal material layer 30 is a medical agent, the protective fiber layer 40 is cotton and linen fiber cloth, and the repair dissolving layer 10, the isolation breathable layer 20, the hemostatic medicinal material layer 30 and the wrapping outer layer 40 are solidified together by cross-linking and pasting.

[0080] As a further improvement to the present invention, the thickness ratio among the repairing and dissolving layer 10, the insulating gas-permeable layer 20, the hemostatic medicinal material layer 30 and the wrapping outer layer 40 is 4:1:3:2. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention belongs to the technical field of medical products, relates to a material for stopping bleeding and in particular relates to bionic cloth for stopping bleeding. The bionic cloth for stopping bleeding has a multilayered structure and comprises a repairing dissolving layer, an isolation and ventilation layer, a bleeding stopping medicine layer and a covering outer layer in sequence, wherein the repairing dissolving layer is cyanoacrylate tissue glue; the isolation and ventilation layer is formed by weaving cotton and hemp fibers; the bleeding stopping medicine layer is a medical treatment medicament; the covering outer layer is cotton and hemp fiber cloth; the repairing dissolving layer, the isolation and ventilation layer, the bleeding stopping medicine layer and the coveringouter layer are stuck and cured together through crosslinking; the bleeding stopping medicine layer is prepared from the following components in percentage by mass: 22 to 24 percent of mannitol, 0.5 to 12.6 percent of chitosan, 9 to 22 percent of vitamin C, 5.2 to 6.5 percent of dexamethasone, 2.0 to 2.2 percent of thrombin, 2.0 to 3.2 percent of polyvinyl alcohol, 0.2 to 0.5 percent of sodium dodecyl sulfonate, 0.5 to 7.2 percent of modified zeolite and the balance of starch micro-pore polysaccharide granules. After the product absorbs a lot of blood, the volume is expanded so that blood vessel ruptures or wounds are sealed and a barrier is provided for a bleeding stopping opening; the bionic cloth has a more rapid healing speed and a better effect.

Description

Technical field [0001] The invention belongs to the technical field of medical supplies, and relates to a material for hemostasis. Background technique [0002] Hemostasis is an important step in emergency medical treatment. When patients undergo surgical treatment and sudden trauma in daily life, rapid hemostasis is required. In the harsh environment of war and complex emergencies, emergency treatment of war and trauma is achieved. Fast and effective hemostasis is particularly important. At present, the hemostatic materials on the market mainly include fibrin glue, gelatin sponge, microporous inorganic materials, carboxymethyl cellulose soluble hemostatic gauze and so on. They are effective in hemostasis, but they also have shortcomings: products such as fibrin glue source, zeolite, fiber, etc., have high cost, poor fusion absorption performance, lack of repairing scars, single performance, low hemostatic efficiency, poor applicability, and easy to spread diseases Collagen rel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61L15/42A61L15/44A61L15/28A61L15/18A61L15/20
CPCA61L15/42A61L15/18A61L15/20A61L15/28A61L15/44A61L2300/102A61L2300/216A61L2300/236A61L2300/254A61L2300/41A61L2300/418A61L2300/606A61L2400/04C08L5/08
Inventor 朱梅佳高芮贾浩李紫薇
Owner 朱梅佳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products